Cite
Robman L, Guymer R, Woods R, et al. Age-related macular degeneration in a randomized controlled trial of low-dose aspirin: Rationale and study design of the ASPREE-AMD study. Contemp Clin Trials Commun. 2017;6:105-114doi: 10.1016/j.conctc.2017.03.005.
Robman, L., Guymer, R., Woods, R., Ward, S., Wolfe, R., Phung, J., Hodgson, L., Makeyeva, G., Aung, K. Z., Gilbert, T., Lockery, J., Le-Pham, Y. A., Orchard, S., Storey, E., Abhayaratna, W., Reid, D., Ernst, M. E., Nelson, M., Reid, C., & McNeil, J. (2017). Age-related macular degeneration in a randomized controlled trial of low-dose aspirin: Rationale and study design of the ASPREE-AMD study. Contemporary clinical trials communications, 6105-114. https://doi.org/10.1016/j.conctc.2017.03.005
Robman, Liubov, et al. "Age-related macular degeneration in a randomized controlled trial of low-dose aspirin: Rationale and study design of the ASPREE-AMD study." Contemporary clinical trials communications vol. 6 (2017): 105-114. doi: https://doi.org/10.1016/j.conctc.2017.03.005
Robman L, Guymer R, Woods R, Ward S, Wolfe R, Phung J, Hodgson L, Makeyeva G, Aung KZ, Gilbert T, Lockery J, Le-Pham YA, Orchard S, Storey E, Abhayaratna W, Reid D, Ernst ME, Nelson M, Reid C, McNeil J. Age-related macular degeneration in a randomized controlled trial of low-dose aspirin: Rationale and study design of the ASPREE-AMD study. Contemp Clin Trials Commun. 2017 Jun;6:105-114. doi: 10.1016/j.conctc.2017.03.005. Epub 2017 Mar 27. PMID: 28736754; PMCID: PMC5518696.
Copy
Download .nbib